about
The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomasDeregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.Colorectal adenomas contain multiple somatic mutations that do not coincide with synchronous adenocarcinoma specimensCross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesB-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signaturesPLCG1 mutations in cutaneous T-cell lymphomas.CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.Transcriptional signature of Ecteinascidin 743 (Yondelis, Trabectedin) in human sarcoma cells explanted from chemo-naive patients.Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma.Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.Correction: Colorectal adenomas contain multiple somatic mutations that do not coincide with synchronous adenocarcinoma specimens.Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.Somatic hypermutation signature in B-cell low-grade lymphomas.Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.miR-217 is an oncogene that enhances the germinal center reactionTCL1A expression delineates biological and clinical variability in B-cell lymphomaVariability in the Degree of Expression of Phosphorylated I B in Chronic Lymphocytic Leukemia Cases With Nodal InvolvementClonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemiaWhole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesisApplied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTORAdvanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways
P50
Q26992198-A5CB1F5E-FDB4-4738-9D63-534DE015CBC7Q34033355-8890DF83-5816-4C5C-AAEE-63654CF8BD04Q34248932-D453272D-0897-4407-A1DC-3A6811B39B3FQ35180651-BFE74719-E4BE-4E26-BDBA-B0C235A9AFADQ36292245-96D2B600-B534-425D-B822-E356679558BCQ36372043-522030D3-B154-4ECD-80DE-4A318EB347A9Q38185363-0ADDECD9-8203-4455-B8A2-78B4566A1F9EQ38839023-077B6514-B403-48DE-8BF4-ADE3822EFAA5Q39027098-B05D64F2-2BD7-4528-8CC5-4B678EDF17B4Q40315089-5A199F65-138F-4C88-AD1E-2E88C271CB32Q40421739-43EAC741-C8F6-45D7-986E-662AD625F75CQ40491492-82EE6151-FEFC-47D9-91C2-3AE760EDF020Q41341337-0B915D18-3326-4EAC-B580-D8DB7652FD20Q42341705-414BB98A-C256-4E32-BC47-EB4ABE68AA8DQ42747287-6C690D63-52DB-484C-BDF3-C3D4D77C0535Q42784521-3AF4B663-E44F-4BC0-9AAE-67DDEC628F43Q43227140-7E9F8DC2-ED05-4F87-BA0C-280BA0D14961Q45364712-28E7EC5F-26A6-4742-BD45-4D16058F94BDQ46538001-1FECD9DA-7346-404B-BAEB-5910DA351C98Q50219435-87293BD4-0B40-4EA7-829E-987E77E9F3D7Q52947124-00293578-1201-4A62-A3E1-228B0C501EE1Q54271169-724B624B-DA8F-4775-81FA-115EAEA80AF4Q54502320-51800EDB-A249-4D21-B4D9-809123577D49Q58010769-BFAD31AA-2B0D-41B1-A46C-7E836E60DF82Q58010893-8D33245D-C86F-4C23-8B58-0ED8622C9046Q58010985-9EA04D78-18D3-43B3-BC33-4431F2EF23E7Q61806591-2FF356A3-64CE-409D-843F-CEDC1DF0AABDQ88138808-A152B40F-7746-413F-8CE5-A2C3DD9EEA13Q90968177-3E1C8670-BE16-4E26-A7C3-152F11B33613Q91722156-92C4A994-02EF-4377-8605-A974EAD9F76E
P50
description
researcher
@en
wetenschapper
@nl
name
Nerea Martinez
@en
Nerea Martinez
@nl
type
label
Nerea Martinez
@en
Nerea Martinez
@nl
prefLabel
Nerea Martinez
@en
Nerea Martinez
@nl
P106
P31
P496
0000-0002-3983-0867